CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
B

Omega-3/fish intake

Lifestyle & BehavioralBehavior / exposureprotectivemodifiable
38
evidence score

Also known as: Fish/omega-3 intake, fish consumption, omega 3, omega-3

PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 14.1meta-analyses: 9.1trials: 15genetic: 0MR bonus:

References (25)

2 meta-analyses / systematic reviews

Clinical trials (48)

NCTTitleStatusTypeInterventions
NCT07331103RESOLving INflammation Through Diet for Health Multicenter, Prospective Randomized, Controlled and Open- Label to Examine the Impact of a Diet Enriched in Omega 3 Fatty Acids of Animal and Vegetal Origin on Circulating Lipid-driven Pro-/Antiinflammatory Balance in Subjects at Moderate to High Cardiovascular Risk.RECRUITINGINTERVENTIONALFish Oil, Camelina oil, Vitamin E
NCT07394517Efficacy of Phospholipid Omega-3 (Ruby-O) Versus Conventional Omega-3 on the Omega-3 Index in Patients With Mixed Dyslipidemia: A 24-Week Randomized, Double-Blind, Parallel TrialNOT YET RECRUITINGINTERVENTIONALPhospholipid Omega-3, Phospholipid Omega-3, Triglyceride Omega-3
NCT07241377A Randomized, Double-blind Placebo-controlled Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources in Natural Triglyceride Form to One Fish Source in Re-esterified Triglyceride Form (GOBO 2 Study)ACTIVE NOT RECRUITINGINTERVENTIONALlife'sTM omega O1035DS nTG, life'sTM omega O3020DS nTG, MEG-3 3323rTG
NCT05331807The Effects of Combined Omega-3 and Vitamin D Supplementation on Nutritional Status, Quality of Life and Inflammatory Markers Among the Breast Cancer Women in Gaza StripCOMPLETEDINTERVENTIONALOmega-3 FA, Vitamin D, Combined Omega-3 and Vitamin D Supplementation
NCT06154408Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms: A Randomized, Double-blind, Placebo-controlled TrialCOMPLETEDINTERVENTIONALomega-3 fatty acids, Placebo
NCT04647604Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids - A Single-blind, Randomized, Placebo-controlled Feasibility StudyCOMPLETEDINTERVENTIONALOmegaven®, Sodium chloride
NCT04140201Evaluation of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic PatientsUNKNOWNINTERVENTIONALSimvastatin 40mg, Fenofibrate 200mg, Omega 3 fatty acid
NCT03661047OMICC: OMega-3 Fatty Acid for the Immune Modulation of Colorectal CancerWITHDRAWNINTERVENTIONALAMR101 (VASCEPA, icosapent ethyl)
NCT04301336Comparative Effectiveness of the Different Treatment Modalities for Management of Vaso-occlusive Painful Crisis in Pediatric Sickle Cell DiseaseCOMPLETEDINTERVENTIONALOmega 3, Vit D, Zinc sulfate
NCT04126330Effect of Omega-3 and Probiotic Dietary Supplements on Elevated High Sensitivity C-reactive Protein (Hs-CRP) as a Marker of Low-grade Inflammation: Targeting Inflammation and Intestinal Barrier Function in the Elderly and ObeseCOMPLETEDINTERVENTIONALProbiotic, Omega-3, Vitamin D supplement, Placebo
NCT03127345Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal HealthWITHDRAWNINTERVENTIONALOmegaven, Intralipid
NCT04051034Heat Therapy and Omega 3 on Metabolic and Cardiovascular HealthUNKNOWNINTERVENTIONALOmega 3, Placebo
NCT04005573Assessing the Combined Effect of Omega-3 Fatty Acid and Vitamin D3 on Lipid Profile Levels and Oxidized Low Density Lipoprotein: a Randomized Controlled Trial in Males and Females With Vitamin D DeficiencyCOMPLETEDINTERVENTIONALVD3, omega 3- FA, VD3 and omega- 3FA
NCT03510715An Open-Label Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial HypercholesterolemiaCOMPLETEDINTERVENTIONALAlirocumab SAR236553 (REGN727), Atorvastatin, Simvastatin
NCT03510884A Randomized, Double-Blind, Placebo-Controlled Study Followed by an Open Label Treatment Period to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCOMPLETEDINTERVENTIONALAlirocumab SAR236553 (REGN727), Rosuvastatin, Atorvastatin
NCT04201938Probiotic With Omega-3 Fatty Acids on Obesity and Insulin Resistance Management in Patients With Type 2 DiabetesCOMPLETEDINTERVENTIONALSymbiter-Omega, Placebo
NCT02890992An 8-Week Open-Label, Sequential, Repeated Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Followed by an Extension PhaseCOMPLETEDINTERVENTIONALalirocumab SAR236553 (REGN727), statins, ezetimibe
NCT02762539Omega3 PUFA in Head TrauamUNKNOWNINTERVENTIONALomega-3 enriched SMOF lipid emusion
NCT02642159A Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Alirocumab Versus Usual Care in Patients With Type 2 Diabetes and Mixed Dyslipidemia at High Cardiovascular Risk With Non-HDL-C Not Adequately Controlled With Maximally Tolerated Statin TherapyCOMPLETEDINTERVENTIONALAlirocumab, Statins, Ezetimibe
NCT03072823Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases: a Double-blind Placebo-controlled Therapeutic TrialCOMPLETEDINTERVENTIONALn-3 Polyunsaturated fatty acid, placebo
NCT02376621Nutrition Products - An Open-Label, Randomised, Single-Dose Study to Evaluate the Bioavailability of Omega-3 Based Dietary Supplements Under Fasting Conditions in Healthy Male and Female SubjectsCOMPLETEDINTERVENTIONALPronovaPure 150:500 triglycerides, Pronovum PRF-048, Pronovum PRF-037
NCT01780974Pilot Study: Lipoic Acid and Omega-3 Fatty Acid for Alzheimer's Disease PreventionCOMPLETEDINTERVENTIONALLipoic Acid plus Omega-3 Fatty Acids, Placebo
NCT02036307Supplementation With Omega-3: Mechanism of ActionTERMINATEDINTERVENTIONALDHA-enriched, EPA-enriched
NCT04208308Comparison of Effect of Animal and Plant Sources of Omega-3 PUFA in Prevention of Cardiovascular and Metabolic DiseasesUNKNOWNINTERVENTIONALChia seeds supplementation (25 g), Chia seeds supplementation (15 g), Combine supplementation: chia seeds (15g) and fish oil Maxi Cor 70+20
NCT02178501The Effect of Omega-3 Polyunsaturated Acids Supplementation on Endothelial Function, Oxidative Stress, Platelet Aggregation, Blood Coagulation and Inflammation in Patients With Type 2 Diabetes and Cardiovascular DiseaseCOMPLETEDINTERVENTIONALOmega-3 PUFA
NCT01301794Study of the Effects of Lovaza (Omega 3 Fatty Acids) On Lipoprotein Particles and Their Transcriptional EffectsUNKNOWNINTERVENTIONALOmega 3 fatty acid (Lovaza)
NCT01521845Phase 3 Study of Poly Unsaturated Fatty Acids of Omega 3 as an Anti Platelet Agent on Biomarkers of Cardiac Necrosis Including CKMB and Troponin I and Inflammation Marker CRPCOMPLETEDINTERVENTIONALomega 3
NCT02117960Assessing the Effects of Omega-3 Supplementation on Serum HSP27, HSP70, YKL40, BMP-4 Levels in Male Patient With Coronary Artery DiseaseCOMPLETEDINTERVENTIONALOmega-3, Placebo
NCT01078909Dose Response Effects of Marine Omega-3 Fatty Acids on InflammationCOMPLETEDINTERVENTIONALEicosapentaenoic Acid and Docosahexaenoic Acid (EPA + DHA)
NCT01526824The Effects of Polyunsaturated Omega-3 Fatty Acids (Lovaza) on Patients Taking Clopidogrel +/- Aspirin Who Have Suffered an Ischemic Stroke/TIA and/or Are Candidates for Neuroendovascular Stenting.UNKNOWNINTERVENTIONALomega-3 polyunsaturated fatty acids (Lovaza)
NCT01310270The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and InflammationCOMPLETEDINTERVENTIONALPro-Omega, Omega 3 Fatty Acid
NCT01367145OMEGA-3-POLYUNSATURATED FATTY-ACIDS (n3-PUFA) IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: EFFECTS ON ENDOTHELIAL FUNCTION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIALCOMPLETEDINTERVENTIONALOMACOR, Placebo
NCT01194063Use of Omegaven for Parenteral Nutrition Associated Liver DiseaseCOMPLETEDINTERVENTIONALOmega-3 fish oil lipid emulsion
NCT01799720Effect of Omega-3 Dietary Supplements With Different Oxidation Levels in the Lipidic Profile of Women: a Randomized Controlled TrialCOMPLETEDINTERVENTIONALLess oxidized oil and diet, More oxidized oil and diet, Hypercholesterolemic diet
NCT01343342Genes, Omega-3 Fatty Acids and Cardiovascular Disease Risk FactorsACTIVE NOT RECRUITINGINTERVENTIONALn-3 PUFA supplementation
NCT00915902Fish Oil Treatment for Dyslipidemia Associated With Children and AdolescentsCOMPLETEDINTERVENTIONALOmega-3-acid ethyl esters, Placebo
NCT00826020Prospective Evaluation of a Parenteral Omega-3 Fatty Acid Preparation (Omegaven™) in Therapy of Patients With TPN-Induced CholestasisCOMPLETEDINTERVENTIONALOmegaven™
NCT01061554Correlation Between Level of Polyunsaturated Fatty Acid EPA and DHA in Blood After Digestion of ProBios Omega-3 Concordix™ Compared With Omega-3 Soft Capsules - a PilotCOMPLETEDINTERVENTIONALOmega-3 oils from tri-glycerides, Omega-3 oils from marine phospholipids
NCT00729430Prognostic, Anti-arrhythmic, and Ventricular Remodeling Effects of High Dose Fish Oil in Patients With a Recent Myocardial InfarctionCOMPLETEDINTERVENTIONALOmega-3 Fatty Acids (Fish Oil Supplements), Placebo
NCT00734916Immune Modulation by Omega-3 Versus Omega-6 Based Parenteral Lipids in Healthy VolunteersCOMPLETEDINTERVENTIONALParenteral lipid emulsion (Omegaven), Parenteral lipid emulsion (Intralipid), Parental lipid emulsion (Saline 0.9%)
NCT00435045A Randomized, Double-Blind, Placebo-Controlled, Forced Titration Study to Assess the Efficacy and Safety of Omacor, Co-Administered With Open-Label Atorvastatin Therapy, in Hypertriglyceridemic SubjectsCOMPLETEDINTERVENTIONALLovaza (omega-3-acid ethyl esters) [formerly known as Omacor] plus atorvastatin, atorvastatin
NCT00402363A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of Lovaza for the Prevention of Recurrent, Symptomatic Atrial FibrillationCOMPLETEDINTERVENTIONALomega-3-acid ethyl esters, Placebo
NCT00141232A Multicentre, Randomised, Double Blind Placebo Controlled Trial Evaluating Atorvastatin in Factorial With Omega-3 Fatty Acids Cardiovascular Risk Reduction in Patients With Type 2 DiabetesCOMPLETEDINTERVENTIONALAtorvastatin and Omega-3 fatty acids
NCT00153764Effectiveness of a One-a-Day Cooper Complete Vitamin / Mineral Supplement With or Without Omega-3 Fatty Acid IngestionCOMPLETEDINTERVENTIONALCooper Complete One-A-Day Vitamin Supplement
NCT00620672To Compare Measures of Central Nervous System Maturity of Visual Acuity, Language, Mental and Motor Skill Development in Term Infants Following Maternal Supplementation Wit the n-3 Fatty Acid Docosahexaenoic Acid (DHA) During Gestation.COMPLETEDINTERVENTIONALomega 3 fatty acids, vegetable oil
NCT00257283A Double Blind Comparison of Omacor and Placebo as Secondary Prevention Against Cardiovascular Events in Patients Undergoing Chronic HemodialysisCOMPLETEDINTERVENTIONALOmega-3-acid ethyl esters 90
NCT00764010Diet and Omega-3 Intervention Trial on AtherosclerosisCOMPLETEDINTERVENTIONALNo dietary counseling and omega-3 capsules, Omega-3 capsules and dietary counseling, Dietary counseling, placebo capsules for omega-3
NCT00000461Harvard Atherosclerosis Reversibility Project (HARP)COMPLETEDINTERVENTIONALpravastatin, niacin, cholestyramine

Genetic associations (0)

None linked.